MedPath

Effect of sertraline on semen parameters in men with premature ejaculatio

Phase 2
Conditions
premature ejaculation.
Premature ejaculation
Registration Number
IRCT201111178121N1
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

age18-40; married men without any history of known sexual disorders; no cigarettes smoking or any drug abuse or alcohol consumption; BMI: 20-28. Exclusion criteria: drug holding because of severe adverse effects of sertraline or no suitable effects ( by patient ); loss of patients; patient with current or past history of psychological disorders like depression or chemotherapy or radiotherapy; patient with current or past history of seizure or clinical varichocele ; patient with current or past history of chronic disease like diabetes, cirrhosis, uremia,..; desire to have a child in time of study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Premature ejaculation. Timepoint: 0, 2nd week and 1st, 2nd, 3rd month after treatment. Method of measurement: self reporting questionnaire.;Sperm count. Timepoint: first visit and 3 weeks after that/3 months after treatment and 3 weeks after Completion of treatment. Method of measurement: spermogram.
Secondary Outcome Measures
NameTimeMethod
Drug advers effects. Timepoint: 4th, 8th, 12th week. Method of measurement: self reporting.
© Copyright 2025. All Rights Reserved by MedPath